GDTC

NASDAQ · Equity

CytoMed Therapeutics Limited Ordinary Shares

US Healthcare Biotechnology

Latest week
29 May 2026
Close
1.170000
Fair value
2.342015
Expectation
Undecided 49.05%
Weekly Close Trend Line Fair Value Activity Lines

Chart Summary

Key Points

Week Ending
29 May 2026
Latest Close
1.17
12-Week Change
10.38%
Trend Signal
Inactive
Expectation
Undecided 49.05%
Signal Weeks
0 of 12
Vs Trend Line
Below
Vs Fair Value
Below
Relative Strength
-40.82
Market Dynamics
0.70

Over the latest 12 completed weeks ending 2026-05-29, GDTC rose 10.38%, moving from 1.06 to 1.17. The latest weekly close is below the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -40.82 and has improved across the 12-week window. Market Dynamics is 0.70 on the latest week. Expectation is undecided at 49.05%.